Artykuły w czasopismach na temat „Anti-Tumoral immunity”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Anti-Tumoral immunity”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Riachi, Mansour E., Carolina G. Alcantara Hirsch, Erica Ma, Beny Shapiro, Ammar Javed, Christopher L. Wolfgang i Dafna Bar-Sagi. "Abstract A018: Exercise stimulates anti-tumoral immunity in metastatic PDAC". Cancer Research 84, nr 2_Supplement (16.01.2024): A018. http://dx.doi.org/10.1158/1538-7445.panca2023-a018.
Pełny tekst źródłaBikorimana, Jean-Pierre, Natasha Salame, Simon Beaudoin, Mohammad Balood, Théo Crosson, Jamilah Abusarah, Sebastien Talbot, Raimar Löbenberg, Sebastien Plouffe i Moutih Rafei. "Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity". Cell Reports Medicine 3, nr 3 (marzec 2022): 100534. http://dx.doi.org/10.1016/j.xcrm.2022.100534.
Pełny tekst źródłaLeshem, Yasmin, Emily King, Ronit Mazor, Yoram Reiter i Ira Pastan. "SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma Tumors". Toxins 10, nr 11 (14.11.2018): 470. http://dx.doi.org/10.3390/toxins10110470.
Pełny tekst źródłaGiurini, Eileena F., Mary Beth Madonna, Andrew Zloza i Kajal H. Gupta. "Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression". Cancers 14, nr 12 (14.06.2022): 2923. http://dx.doi.org/10.3390/cancers14122923.
Pełny tekst źródłaRivera-Molina, Yisel, Juan Fueyo, Hong Jiang, Teresa Nguyen, Dong Ho Shin, Gilbert Youssef, Xuejun Fan i in. "EXTH-27. ACTIVATING THE IMMUNITY WITHIN THE TUMOR USING VIROIMMUNOTHERAPY: DELTA-24-RGD ONCOLYTIC ADENOVIRUS ARMED WITH THE IMMUNOPOSITIVE REGULATOR GITRL". Neuro-Oncology 21, Supplement_6 (listopad 2019): vi87. http://dx.doi.org/10.1093/neuonc/noz175.359.
Pełny tekst źródłaCohen-Solal, Joel F. G., Lydie Cassard, Emilie M. Fournier, Shannon M. Loncar, Wolf Herman Fridman i Catherine Sautès-Fridman. "Metastatic Melanomas Express Inhibitory Low Affinity Fc Gamma Receptor and Escape Humoral Immunity". Dermatology Research and Practice 2010 (2010): 1–11. http://dx.doi.org/10.1155/2010/657406.
Pełny tekst źródłaMirlekar, Bhalchandra, i Yuliya Pylayeva-Gupta. "Abstract PO-019: Reprogramming of naïve B cells in pancreatic cancer subverts humoral immunity". Cancer Research 81, nr 22_Supplement (15.11.2021): PO—019—PO—019. http://dx.doi.org/10.1158/1538-7445.panca21-po-019.
Pełny tekst źródłaGeidel, G., M. Maurer, T. Luger i K. Loser. "649 OX40/OX40L and 4-1BB/4-1BBL signaling in cutaneous anti-tumoral immunity". Journal of Investigative Dermatology 136, nr 5 (maj 2016): S115. http://dx.doi.org/10.1016/j.jid.2016.02.690.
Pełny tekst źródłaWu, Deyang, Xiaowei Liu, Jingtian Mu, Jin Yang, Fanglong Wu i Hongmei Zhou. "Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers". Biomolecules 12, nr 3 (2.03.2022): 392. http://dx.doi.org/10.3390/biom12030392.
Pełny tekst źródłaRemsik, Jan, Xinran Tong, Min Jun Li, Ugur Sener, Jessica Wilcox, Kiana Chabot, Russell Kunes i in. "LMD-16. Choroid plexus orchestrates anti-cancer immunity in leptomeninges". Neuro-Oncology Advances 3, Supplement_3 (1.08.2021): iii10—iii11. http://dx.doi.org/10.1093/noajnl/vdab071.041.
Pełny tekst źródłaRevel, Margot, Marie V. Daugan, Catherine Sautés-Fridman, Wolf H. Fridman i Lubka T. Roumenina. "Complement System: Promoter or Suppressor of Cancer Progression?" Antibodies 9, nr 4 (25.10.2020): 57. http://dx.doi.org/10.3390/antib9040057.
Pełny tekst źródłaLee, Eun Jung, Da Hyeon Yun, Seungpil Jung i Serk In Park. "Abstract 2191: Alteration of anti-tumoral immunity in the pre-metastatic bone microenvironment via autonomic nerve system dysfunction". Cancer Research 82, nr 12_Supplement (15.06.2022): 2191. http://dx.doi.org/10.1158/1538-7445.am2022-2191.
Pełny tekst źródłaWang, Xuefeng, Xin Gao, Xin Zhao, Qianting Yang, Yuan Qi, Shayang Zang, Xueguang Zhang i Binfeng Lu. "Tumoral expression of IL-33 promotes Anti-tumor Immune Responses (TUM2P.912)". Journal of Immunology 192, nr 1_Supplement (1.05.2014): 71.36. http://dx.doi.org/10.4049/jimmunol.192.supp.71.36.
Pełny tekst źródłaBrummer, Christina, Tobias Pukrop, Joachim Wiskemann, Christina Bruss, Ines Ugele i Kathrin Renner. "Can Exercise Enhance the Efficacy of Checkpoint Inhibition by Modulating Anti-Tumor Immunity?" Cancers 15, nr 18 (21.09.2023): 4668. http://dx.doi.org/10.3390/cancers15184668.
Pełny tekst źródłaZerdes, Wallerius, Sifakis, Wallmann, Betts, Bartish, Tsesmetzis i in. "STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer". Cancers 11, nr 10 (1.10.2019): 1479. http://dx.doi.org/10.3390/cancers11101479.
Pełny tekst źródłaRosato, Pamela, Jianfang Ning, Noah Veis Gavil, Shaoping Wu, Sathi Wijeyesinghe, Eyob Weyu, Jun Ma i in. "Functional virus-specific memory CD8+ T cells survey glioblastoma". Journal of Immunology 208, nr 1_Supplement (1.05.2022): 121.15. http://dx.doi.org/10.4049/jimmunol.208.supp.121.15.
Pełny tekst źródłaKendal, Joseph K., Michael S. Shehata, Serena Y. Lofftus i Joseph G. Crompton. "Cancer-Associated B Cells in Sarcoma". Cancers 15, nr 3 (19.01.2023): 622. http://dx.doi.org/10.3390/cancers15030622.
Pełny tekst źródłaVeneziani, Irene, Claudia Alicata, Lorenzo Moretta i Enrico Maggi. "The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview". Biomedicines 11, nr 1 (27.12.2022): 64. http://dx.doi.org/10.3390/biomedicines11010064.
Pełny tekst źródłaAraújo, Thaise Gonçalves, Sara Teixeira Soares Mota, Helen Soares Valença Ferreira, Matheus Alves Ribeiro, Luiz Ricardo Goulart i Lara Vecchi. "Annexin A1 as a Regulator of Immune Response in Cancer". Cells 10, nr 9 (30.08.2021): 2245. http://dx.doi.org/10.3390/cells10092245.
Pełny tekst źródłaKim, Do-Hyun, Sangho Lim, Hong-Gyun Lee, Chun Geun Lee, Jack A. Elias i Je-Min Choi. "Regulation of Chitinase-3-like-1 in T cell enhances anti-tumoral T cell responses to suppress lung metastasis". Journal of Immunology 200, nr 1_Supplement (1.05.2018): 57.27. http://dx.doi.org/10.4049/jimmunol.200.supp.57.27.
Pełny tekst źródłaTrandafir, Maria-Florina, Octavian Savu, Daniela Pasarica, Coralia Bleotu i Mihaela Gheorghiu. "Interleukin-6 as a Director of Immunological Events and Tissue Regenerative Capacity in Hemodialyzed Diabetes Patients". Medical Sciences 12, nr 2 (15.06.2024): 31. http://dx.doi.org/10.3390/medsci12020031.
Pełny tekst źródłaQiao, Rong, Rong Xiao, Zhong Chen, Jingwei Jiang, Chenghua Yuan, Shuxiang Ning, Jihong Wang i Zunchun Zhou. "Cloning, Expression and Inhibitory Effects on Lewis Lung Carcinoma Cells of rAj-Tspin from Sea Cucumber (Apostichopus japonicus)". Molecules 27, nr 1 (30.12.2021): 229. http://dx.doi.org/10.3390/molecules27010229.
Pełny tekst źródłaMori, Shiori, Rina Fujiwara-Tani, Shingo Kishi, Takamitsu Sasaki, Hitoshi Ohmori, Kei Goto, Chie Nakashima i in. "Enhancement of Anti-Tumoral Immunity by β-Casomorphin-7 Inhibits Cancer Development and Metastasis of Colorectal Cancer". International Journal of Molecular Sciences 22, nr 15 (30.07.2021): 8232. http://dx.doi.org/10.3390/ijms22158232.
Pełny tekst źródłaKim, Hyun-Jin, Jang Hyun Park, Hyeon Cheol Kim, Chae Won Kim, In Kang i Heung Kyu Lee. "Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma". Journal of Immunology 210, nr 1_Supplement (1.05.2023): 84.11. http://dx.doi.org/10.4049/jimmunol.210.supp.84.11.
Pełny tekst źródłaBeissert, S., S. Grabbe, M. Voskort, T. A. Luger, T. Schwarz i R. D. Granstein. "Effects of senescence on induction and elicitation of protective anti-tumoral immunity by langerhans cells in mice". Journal of Dermatological Science 16 (marzec 1998): S90. http://dx.doi.org/10.1016/s0923-1811(98)83534-2.
Pełny tekst źródłaCharrier, Emily, Rémi Vernet, Frank Schwenter, Patricia Luy, Alena Donda i Nicolas Mach. "A Functional GM-CSF Receptor on Dendritic Cells Is Required for Efficient Protective Anti-Tumor Immunity". Immuno 1, nr 3 (6.08.2021): 240–52. http://dx.doi.org/10.3390/immuno1030016.
Pełny tekst źródłaKim, Seon-Hee, Chungyong Han, Byoung S. Kwon i Beom K. Choi. "CD4 depletion potentiates anti-tumor immunity in adoptive immunotherapy by increasing IL-18Rαhi endogenous CD8+ T cells". Journal of Immunology 204, nr 1_Supplement (1.05.2020): 170.7. http://dx.doi.org/10.4049/jimmunol.204.supp.170.7.
Pełny tekst źródłaBishani, Ali, i Elena L. Chernolovskaya. "Activation of Innate Immunity by Therapeutic Nucleic Acids". International Journal of Molecular Sciences 22, nr 24 (12.12.2021): 13360. http://dx.doi.org/10.3390/ijms222413360.
Pełny tekst źródłaZhang, Tao, Yu Wang, Qing Li, Liangyu Lin, Chunliang Xu, Yueqing Xue, Mingyuan Hu, Yufang Shi i Ying Wang. "Mesenchymal stromal cells equipped by IFNα empower T cells with potent anti-tumor immunity". Oncogene 41, nr 13 (10.02.2022): 1866–81. http://dx.doi.org/10.1038/s41388-022-02201-4.
Pełny tekst źródłaRafei, M., J. Abusarah i R. Shammaa. "The next generation cancer vaccines: genetically engineered mesenchymal stromal cells exhibit robust anti-tumoral immunity surpassing dendritic cells". Cytotherapy 22, nr 5 (maj 2020): S31. http://dx.doi.org/10.1016/j.jcyt.2020.03.015.
Pełny tekst źródłaCho, Jeong Hyun, Hyo-Ji Lee, Hyun-Jeong Ko, Byung-Il Yoon, Jongseon Choe, Keun-Cheol Kim, Tae-Wook Hahn i in. "The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma". Oncotarget 8, nr 15 (15.02.2017): 24932–48. http://dx.doi.org/10.18632/oncotarget.15326.
Pełny tekst źródłaPandey, Sanjay, Claudia G. Chavez, Indranil Basu, Andy Minn i Chandan Guha. "Abstract 3444: Administration of anti-CD40 enhances local and systemic antitumor efficacy of radiotherapy in allograft tumor model of a check-point blockade resistant melanoma". Cancer Research 82, nr 12_Supplement (15.06.2022): 3444. http://dx.doi.org/10.1158/1538-7445.am2022-3444.
Pełny tekst źródłaPoccia, F., B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, M. López-Botet, J. J. Fournié i M. L. Gougeon. "CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes." Journal of Immunology 159, nr 12 (15.12.1997): 6009–17. http://dx.doi.org/10.4049/jimmunol.159.12.6009.
Pełny tekst źródłaLiu, Haiyan. "Differential roles of tumoral and systemic IL-1α in the development of hepatocellular carcinoma". Journal of Immunology 200, nr 1_Supplement (1.05.2018): 178.24. http://dx.doi.org/10.4049/jimmunol.200.supp.178.24.
Pełny tekst źródłaDorrier, Cayce, Felagot Abebe, Olivia Pak, Emily De-Bodene i Joshua Wang. "Abstract LB117: Virus-inspired Particles (ViPs) harnessing cytomegalovirus immune memory for local and systemic cancer immunotherapy". Cancer Research 84, nr 7_Supplement (5.04.2024): LB117. http://dx.doi.org/10.1158/1538-7445.am2024-lb117.
Pełny tekst źródłaAwasthi, Deepika, i Aditya Sarode. "Neutrophils at the Crossroads: Unraveling the Multifaceted Role in the Tumor Microenvironment". International Journal of Molecular Sciences 25, nr 5 (2.03.2024): 2929. http://dx.doi.org/10.3390/ijms25052929.
Pełny tekst źródłaCannon, Anthony Michael, i Mark H. Kaplan. "IL-9 responsive macrophages utilize Arginase 1 to enhance lung tumor growth". Journal of Immunology 210, nr 1_Supplement (1.05.2023): 84.09. http://dx.doi.org/10.4049/jimmunol.210.supp.84.09.
Pełny tekst źródłaLan, Keng-Hsueh, Ying-Chun Sheng, Keng-Li Lan, KyungMann Kim, Sung-Hsin Kuo i Zachary Morris. "Abstract 1098: Combination of a DNA vaccine-induced immune checkpoint blockade and radiation therapy induces anti-tumor immunity". Cancer Research 83, nr 7_Supplement (4.04.2023): 1098. http://dx.doi.org/10.1158/1538-7445.am2023-1098.
Pełny tekst źródłaHoelzinger, Dominique, Ana Dominguez, Kevin Pollock, Joseph Lustgarten, Peter Cohen i Sandra Gendler. "IL-9 strategy to perturb Treg function and enhance anti-tumor immunity (P4273)". Journal of Immunology 190, nr 1_Supplement (1.05.2013): 140.9. http://dx.doi.org/10.4049/jimmunol.190.supp.140.9.
Pełny tekst źródłaNiavarani, Seyedeh Raheleh, Christine Lawson i Lee-Hwa Tai. "Treatment of Metastatic Disease through Natural Killer Cell Modulation by Infected Cell Vaccines". Viruses 11, nr 5 (11.05.2019): 434. http://dx.doi.org/10.3390/v11050434.
Pełny tekst źródłaCarrel, Sabrina, Michelle Li, Batul Al-Zubeidy, Dominic Zavala, Edgar Gonzales, Aaron Baugh, Sofi Castanon i in. "Abstract A028: Disparities in suppressive immunity in Hispanic/Latina patients with hormone receptor positive breast cancer". Cancer Research 84, nr 3_Supplement_1 (1.02.2024): A028. http://dx.doi.org/10.1158/1538-7445.advbc23-a028.
Pełny tekst źródłaEverts, Anne, Melissa Bergeman, Grant McFadden i Vera Kemp. "Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses". Biomedicines 8, nr 11 (5.11.2020): 474. http://dx.doi.org/10.3390/biomedicines8110474.
Pełny tekst źródłaTiemeijer, Bart M., Lucie Descamps, Jesse Hulleman, Jelle J. F. Sleeboom i Jurjen Tel. "A Microfluidic Approach for Probing Heterogeneity in Cytotoxic T-Cells by Cell Pairing in Hydrogel Droplets". Micromachines 13, nr 11 (4.11.2022): 1910. http://dx.doi.org/10.3390/mi13111910.
Pełny tekst źródłaPeggs, Karl S., Sergio A. Quezada, Tyler R. Simpson i James P. Allison. "Dissociation of Systemic and Local Anti-Tumor Immunity Following Depletion of Regulatory T Cells Limits Therapeutic Activity in Established Tumors." Blood 110, nr 11 (16.11.2007): 286. http://dx.doi.org/10.1182/blood.v110.11.286.286.
Pełny tekst źródłaSaito, Yasuyuki, Satomi Komori, Takenori Kotani, Yoji Murata i Takashi Matozaki. "The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity". Cancers 14, nr 8 (13.04.2022): 1976. http://dx.doi.org/10.3390/cancers14081976.
Pełny tekst źródłaOrlandella, Rachael M., Shannon Boi, Daniel Smith i Lyse A. Norian. "Understanding the effects of a calorie restriction mimetic on renal cancer progression and CD8 T cell immunity". Journal of Immunology 198, nr 1_Supplement (1.05.2017): 76.12. http://dx.doi.org/10.4049/jimmunol.198.supp.76.12.
Pełny tekst źródłaCrescenzi, Elvira, Antonio Leonardi i Francesco Pacifico. "NGAL as a Potential Target in Tumor Microenvironment". International Journal of Molecular Sciences 22, nr 22 (15.11.2021): 12333. http://dx.doi.org/10.3390/ijms222212333.
Pełny tekst źródłaGuth, Amanda, Emily Monk, Rajesh Agarwal, Bryan C. Bergman, Karin A. Zemski-Berry, Angela Minic, Kimberly Jordan i Isabel R. Schlaepfer. "Targeting Fat Oxidation in Mouse Prostate Cancer Decreases Tumor Growth and Stimulates Anti-Cancer Immunity". International Journal of Molecular Sciences 21, nr 24 (18.12.2020): 9660. http://dx.doi.org/10.3390/ijms21249660.
Pełny tekst źródłaCano, Carla E., Christine Pasero, Aude De Gassart, René Hoet, Emmanuel Scotet, Erwan Mortier, Agnes Quemeneur i in. "BTN2A, a New Immune-Checkpoint Targeting Vg9Vd2 T Cell Cytotoxicity". Blood 134, Supplement_1 (13.11.2019): 1044. http://dx.doi.org/10.1182/blood-2019-128658.
Pełny tekst źródłaBruno, Gennaro, Nicoletta Nastasi, Angela Subbiani, Alessia Boaretto, Annalisa Tondo, Claudio Favre i Maura Calvani. "Abstract 3887: β3-adrenergic receptor sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma". Cancer Research 82, nr 12_Supplement (15.06.2022): 3887. http://dx.doi.org/10.1158/1538-7445.am2022-3887.
Pełny tekst źródła